DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Benzimidazole is an investigational drug.
There have been 12 clinical trials for Benzimidazole. The most recent clinical trial was a Phase 1 trial, which was initiated on January 1st 2013.
The most common disease conditions in clinical trials are Helminthiasis, Neoplasms, Plasma Cell, and Anemia, Hemolytic. The leading clinical trial sponsors are Sidney Kimmel Comprehensive Cancer Center, University Ghent, and University of Washington.
There are three US patents protecting this investigational drug and forty-three international patents.
Recent Clinical Trials for Benzimidazole
|Albendazole Plus High Dose Ivermectin for Trichuriasis in Pediatric Patients||Alejandro Krolewiecki||Phase 2|
|Validating Egg-based Diagnostics and Molecular Markers for the Spread of Anthelmintic Resistance||Swiss Tropical & Public Health Institute||N/A|
|Validating Egg-based Diagnostics and Molecular Markers for the Spread of Anthelmintic Resistance||University Ghent||N/A|
Top disease conditions for Benzimidazole
Top clinical trial sponsors for Benzimidazole
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Benzimidazole||See Pricing||Materials for organic light emitting diode||UNIVERSAL DISPLAY CORPORATION (Ewing, NJ)||See Pricing|
|Benzimidazole||See Pricing||Small molecule HSP70 inhibitors||The Trustees of the University of Pennsylvania (Philadelphia, PA) The Wistar Institute of Anatomy and Biology (Philadelphia, PA)||See Pricing|
|Benzimidazole||See Pricing||Derivatives of 2-(1,2,4-triazol-3-ylsulfanyl)-N-1,3,4-thiadiazol-2-yl acetamide which are useful for the treatment of inter alia diabetes||APOGLYX AB (Lund, SE)||See Pricing|
|Benzimidazole||See Pricing||Pyrene derivative, organic light-emitting medium, and organic electroluminescent element containing pyrene derivative or organic light-emitting medium||IDEMITSU KOSAN CO., LTD. (Tokyo, JP)||See Pricing|
|Benzimidazole||See Pricing||Aromatic amine derivative, and organic electroluminescent element using same||IDEMITSU KOSAN CO., LTD. (Chiyoda-ku, JP)||See Pricing|
|Benzimidazole||See Pricing||Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators||HMI Medical Innovations, LLC (Southfield, MI)||See Pricing|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Benzimidazole||European Patent Office||2121871||2027-03-08||See Pricing|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|